Connect with us

Hi, what are you looking for?

[t4b-ticker]

World

Sputnik V 80% Effective 6-8 Months After Second Dose, Says RDIF Chief

Sputnik team believes that adenoviral vaccines provide for longer efficacy than mRNA vaccines due to longer antibody and T-cell response.

Sputnik V 80% Effective 6-8 Months After Second Dose, Says RDIF Chief
Sputnik V 80% Effective 6-8 Months After Second Dose, Says RDIF Chief. (Photo:File)

Moscow: The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine demonstrating it is 80% effective against coronavirus infection from 6th to 8th months after administering the second dose. Efficacy of Sputnik V on 6-8 months is much higher than officially published efficacy of mRNA vaccines.

Sputnik team believes that adenoviral vaccines provide for longer efficacy than mRNA vaccines due to longer antibody and T-cell response. The data is based on the number of COVID infections in San Marino in November 2021. Efficacy was calculated based on data obtained from over 18,600 individuals fully vaccinated with Sputnik V not less than 5 months before November.

The hospitalization rate with Covid infection following vaccination with Sputnik V in San Marino was only 0.75 per 1,000 people during the entire mass vaccination in the country from February to November 2021. This rate is more than 2 times lower than that of any other vaccine used in the country. Over 70% of the adult population of San Marino have been vaccinated with Sputnik V.

ALSO READ: Laos And San Marino Authorize One-Shot Sputnik Light Covid-19 Vaccine

An article published in EClinicalMedicine (an open access clinical journal published by The Lancet, one of the world’s most respected medical journals) in July demonstrated that the Russian vaccine has a high safety profile in San Marino. In particular, Sputnik V shows high tolerability profile in ≥60 age group with nearly all reported adverse events following immunization being mild or moderate and lasting less than 2 days.

Sputnik V pioneered the heterogeneous boosting approach (a “vaccine cocktail” using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component). This approach was proven to be successful in creating a longer and more durable immunity against coronavirus.

Sputnik team offered its booster shot (one-shot Sputnik Light vaccine) to other vaccines to lengthen and strengthen their immune response and took the lead in initiating partnerships around the world to conduct joint studies on the combination of Sputnik Light with vaccines of other producers.

(With Inputs from PTI)

ALSO READ: Russia’s Single Dose Sputnik Light Covid-19 Vaccine Set For December Launch In India

You May Also Like

World

The World Health Organization (WHO) on Friday declared the new coronavirus strain, first found in South Africa, as a ‘variant of concern’ and named...

India

The meeting comes amid rising global concerns over a new strain of the coronavirus which the World Health Organization has named 'Omicron' and classified...

India

In an Exclusive interview to India Ahead, Sangma explained why he decided to leave the Congress along with 11 other MLAs to merge with...

India

In the run-up to the assembly elections scheduled to be held in 2022 in five states, Uttar Pradesh polls is the most crucial and...

Advertisement